T-Oligo as an Anticancer Agent in Colorectal Cancer

Biochemical and Biophysical Research Communications - United States
doi 10.1016/j.bbrc.2014.03.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Curcumin as an Anticancer Agent in Malignant Mesothelioma: A Review

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2020English

Aspirin as a Chemoprevention Agent for Colorectal Cancer

Current Drug Metabolism
Clinical BiochemistryPharmacology
2012English

Tetrac as an Anti-Angiogenic Agent in Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2019English

Repurposing the Serotonin Agonist Tegaserod as an Anticancer Agent in Melanoma: Molecular Mechanisms and Clinical Implications

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2020English

QSAR Treatment of Meisoindigo Derivatives as a Potentbreast Anticancer Agent

Acta Chimica Asiana
2019English

Synthesis, Characterisation and Evaluation of Oxadiazole as Promising Anticancer Agent

SN Applied Sciences
2020English

Cd₈⁺ and Cd₄⁺ Regulatory T Cells in Colorectal Cancer

Proceedings of the Karelian Research Centre of the Russian Academy of Sciences
2020English

Production and Characterization of Taxol as Anticancer Agent From Aspergillus Terreus

Journal of Pure and Applied Microbiology
Applied MicrobiologyBiotechnologyMicrobiology
2019English

Beclin 1 Acetylation Impairs the Anticancer Effect of Aspirin in Colorectal Cancer Cells

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy